Levetiracetam
100mg/ml
Levetiracetam is an antiepileptic medicine (a medicine used to treat seizures in epilepsy)
Levetiracetam is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy. Levetiracetam is indicated as adjunctive therapy:
- in the treatment of partial onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
- in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.
- in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.
Levetiracetam for infusion is an alternative for patients when oral administration is temporarily not feasible.
| Name & Details | Packaging | Strength | Form | Pack Size |
|---|---|---|---|---|
| Levetiracetam Kensington Pharma Ltd 100mg/ml |
Glass vial | 100mg/ml | Concentrate for soultion for infusion 5ml vial | 10 x 5ml vial |
Pack type: 10 x 10ml glass vial
PIP code: 1235449
Product licence number: 44853/0004
Product EAN Code: 5060467000185
Product Classification: POM Hospital Only
Categories: Anticonvulsants
Support Documentation
If you need further information on this product, please access the current Summary of Product Characteristics (SmPC) and Patient information leaflet (PIL) on the MHRA website using the aforementioned product license number.
MHRA website (click here to open external website in a new window)